Involvement of interleukin-1beta/nitric oxide pathway in the postischemic impairment of long-term potentiation of the rat hippocampus

Neurosci Lett. 2001 Nov 9;313(3):133-6. doi: 10.1016/s0304-3940(01)02271-6.

Abstract

To investigate whether postischemic cerebral dysfunction occurs via the interleukin-1 beta/nitric oxide (IL-1beta/NO) pathway, we examined the effects of an IL-1beta antagonist on long-term potentiation (LTP) impairment and excessive NO production in the rat hippocampus after 10-min global ischemia. Intracerebroventricilar administration of the IL-1beta antagonist attenuated NO production and rescued LTP impairment in the perforant path-dentate gyrus synapses, observed 1 day and 4 days after ischemic insult, respectively. There was an inverse relationship between LTP in the dentate gyrus synapses and hippocampal NO production. Centrally applied IL-1beta mimicked the consequences of transient ischemia in LTP formation and hippocampal NO production in non-ischemic rats. These findings indicate that the IL-1beta/NO pathway is involved in the hippocampal LTP impairment observed in the postischemic brain.

MeSH terms

  • Animals
  • Brain Ischemia / physiopathology*
  • Carotid Arteries / physiology
  • Dentate Gyrus / blood supply
  • Dentate Gyrus / drug effects
  • Dentate Gyrus / physiopathology
  • Hippocampus / blood supply
  • Hippocampus / drug effects
  • Hippocampus / physiopathology*
  • Interleukin-1 / antagonists & inhibitors
  • Interleukin-1 / metabolism*
  • Interleukin-1 / pharmacology
  • Interleukin-1beta
  • Long-Term Potentiation* / drug effects
  • Male
  • Microdialysis
  • Nitric Oxide / metabolism*
  • Peptide Fragments / pharmacology
  • Perforant Pathway / blood supply
  • Perforant Pathway / drug effects
  • Perforant Pathway / physiopathology
  • Rats
  • Rats, Wistar
  • Signal Transduction / drug effects

Substances

  • Interleukin-1
  • Interleukin-1beta
  • Peptide Fragments
  • interleukin 1beta (193-195)
  • Nitric Oxide